Back to search
Drug-Induced Acute Liver Injury
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Drug-Induced Acute Liver Injury trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Drug-Induced Acute Liver Injury trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Drug-induced liver injury (DILI) can lead to potentially fatal complications, such as acute liver failure and even death. In clinical practice, glucocorticoids…
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, an…
The clinical trial will assess the safety of miroliverELAP for the treatment of acute liver failure, severe acute alcohol-associated hepatitis, or acute on chro…
Prospective, single center, open label, randomized controlled trial to explore whether digoxin treatment affects cytokine levels as biomarkers of inflammation i…